Immunohistochemical determination of tumour growth fraction in human ovarian carcinoma

Authors:

Abstract
The proportion of proliferating tumour cells in a tumour (''growth fraction'') was estimated in 30 patients with primary ovarian carcinoma, using monoclonal antibody Ki-67 which reacts with a nuclear antigen present only in proliferating cells. A positive correlation between the ''growth fraction'' and both the clinical stage and histological grade of the tumours was observed. A high ''growth fraction'' was observed in advanced, metastastic and poorly differentiated tumours and a low ''growth fraction'' with early stage, well-differentiated tumours. This information which has not been available previously to clinicians may be of practical value for determining the prognosis, and influencing treatment recommendation.

This publication has 16 references indexed in Scilit: